SynthesisHead & face medicine2026

Botulinum Toxin Type A for Myogenous Temporomandibular Disorders, Focusing on the Duration of Clinical Effects and Dosage Parameters: A Systematic Review.

Ilan Hudson Gomes de Santana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.